Assessing multiple score functions in Rosetta for drug discovery is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 38 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: F31 CA243353
National Institutes of Health
Grant: 5F31CA243353-03
Hybridized structure- and ligand- based drug discovery approaches targeting ASCT2, an amino acid transporter critical for upregulated cell proliferation in numerous cancer types
PhRMA Foundation
FWCI
2.41
Citation Percentile
0.9%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals